Moderna's Early Vaccine Results
Posted on AllSides May 21st, 2020
This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:
THE QUICK FACTS
- On Monday, biotech company Moderna Therapeutics announced in a press release "positive" interim phase 1 data for a COVID-19 vaccine trial. Moderna's stock valuation subsequently surged.
- The company only disclosed information from eight of 45 human subjects, leaving many of the results unknown.
- Many scientific experts have questioned the optimistic press release, citing the small sample size of these results and lack of supporting scientific ...
AllSides Media Bias Rating: Mixed